CROSS JOHN HARRY III (Chief Financial Officer) reported 1 transaction at SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/17/2023ACC: 0001493152-23-005464
Officer· Chief Financial Officer
Since Apr 2020
-1.96K
Net shares
Net seller
$2.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.96K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.96K
Price / share
$1.06
Trade value
$2.08K
% of position
7.6%
2/6/2023
25.89K→23.93K
Total
Net shares
−1.96K
Net value
-$2.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2023 | F · Tax Withholding | −1.96K | $1.06 | $2.08K | 7.6% | 25.89K | 23.93K |
| Total | −1.96K | -$2.08K | ||||||
Derivative Transactions0
No derivative transactions reported